Abstract
A new synthesis of the catechol-O-methyltransferase (COMT) inhibitor, entacapone (E-isomer) has been achieved under mild conditions by amine-mediated demethylation of the precursor 2-Cyano-3-(3- hydroxy-4-methoxy-5-nitrophenyl) prop-2-eneamide, wherein the methoxyl group adjacent to a nitro group gets demethylated under nucleophilic attack. Similar demethylation was achieved on ethyl 2-cyano-3-(3, 4-dimethoxy-5-nitrophenyl) prop-2-enoate, 2-cyano-3-(3,4-dimethoxy-5-nitrophenyl)-N,N-diethylprop-2-enamide, ethyl 2-cyano-3-(3-hydroxy-4-methoxy-5-nitrophenyl) prop-2-enoate and ethyl 2-cyano-3-(4-methoxy-3-nitrophenyl) prop-2-enoate. The scope of demethylation has been studied. Analogues of ethyl 2-cyano-3-(3, 4-dimethoxy-5-nitrophenyl) prop-2-enoate wherein a methoxyl group is not adjacent to a NO 2 group are unaffected and phenolic derivatives yield the amine salts. Entacapone has been converted to salts with organic bases. The crystal structure of the isomer of entacapone (Z-isomer), a significant human metabolite of E-isomer has been established. NMR methods for deriving E and Z geometry and other similar molecules have been successfully established, mainly by studying the proton coupled 13C spectra. Preliminary studies reveal in vitro activity for some compounds against tuberculosis (TB) and dengue.
Similar content being viewed by others
References
Axelrod J and Albers W 1959 Carmine and Clemente D J. Neurochem. 5 68
Richard C, Dodel M D, Karla M, Eggert M D, Marika S, Singer M D, Eichhorn E., M D O. P. M D, Wolfgang H and Oertel M D 1998 Mov. Disord. 13 249
Andrew D, Siderowf M D, Robert G, Holloway M D, MPH and Stern M B 2000 Mov. Disord. 15 439
Axelrod J and Tomchick R 1958 J. Biol. Chem. 233 702
Cedarbaum J M 1987 Clin. Pharmacokinet. 13 141
Quinn N P 1984 Drugs 28 236
Bartholini G and Pletscher A 1975 Pharmacol. Ther. [B] 1 407
Mannisto P T and Kakkola S 1999 Phrmacol. Rev. 51 593
Wikberg T, Vuorela A, Ottoila P and Taskinen J 1993 Drug Metab. Dispos 21 81
Pipuri, Honkanen and Haarala 1991 EP Patent 0,426,468
Veera Reddy A and Rajendiran C 2005 WO Patent 2005063693A1
Cziaky Z 2006 WO Patent 2006064296A 1
Bartra Sanmarti M, Solsona Rocabert J G, Palomo Nicolau F E and Molina Ponce A 2008 WO Patent 2008119793
Srikanth G, Ray Uttam Kumar, Srinivas Rao D V N, Badarinath Gupta P, Lavanya P and Islam Aminul 2012 Synth. Commun. 42 1359
Veerareddy A and Reddy G S 2014 Synth. Commun. 44 1274
Kulkarni P P, Kadam A J, Mane R B, Uday V D and Wadgaonkar P P 1999 J. Chem. Res. (S) 394
Buckle D R and Rockell C 1985 J. Chem. Soc., Perkin Trans. 1 2443
Arcadi A, Cacchi S, Del Rosario M, Fabrizi G and Marinelli F 1996 J. Org. Chem. 61 9280
Nishioka H, Nagasawa M and Yoshida K 2000 Synthesis 2 243
Cahn R S 1931 J. Chem. Soc. 1121
Conreaux D, Belot S, Desbordes P, Monteiro N and Balme G 2008 J. Org. Chem. 73 8619
Brescia A, Arents J, Meislich H and Turk A 1973 In Fundamental of chemistry (3rd ed.) (London: Academic press) p.413
Harisha A S, Nayak S P, Nagarajan K, Guru Row T N and Amar A. Hosamani 2015 Tetrahedron Lett. 56 1427
Zhang S J, Zheng X M and Hu W X 2009 Acta Crystallogr. Sect. E 65 2351
Kametani T, Nyu K and Yamanaka T 1971 Chem. Pharm. Bull. 19 1321
Dai G, Shi D, Zhou L and Huaxue L Y 1995 Chinese J. Appl. Chem. 3 103
Sreenivas Reddy L, Sarah J, Bethune Jeff W. Kampf and Nair Rodriguez-Hornedo 2009 Cryst. Growth Des. 9 378
Mitra A K, Banerjee S K and Sharmistha C 2003 J. Indian Chem. Soc. 80 921
Leppanen J, Wegelius E, Nevalainen T, Jarvinen T, Gynther J and Huuskonen J 2001 J. Mol. Struct. 562 129
Ulrich V, Wolfgang V P, Nagarajan K and Nair M D 1978 HeIv. Chim. Acta 61 607
Francisco D, Joaquin T, Gerard Z, Miguel L, Rene M and Jose G 1995 Synth. Commun. 25 753
(a) Saito T, Goto H, Honda K and Fujii T 1992 Tetrahedron Lett. 33 7553; (b) Angeletti E, Canepa C, Martinetti G and Venturello P 1988 Tetrahedron Lett. 29 2261; (c) Prajapti D, Lekhok K C, Snadhu J S and Ghosh A C 1996 J. Chem. Soc., Perkin Trans. 1 959; (d) Chalais S, Laszlo P and Mathy A 1985 Tetrahedron Lett. 26 4453
Hema R, Parthasarathi V, Ravikumar K, Sridhar B and Pandiarajan K 2006 Acta Crystallogr. Sect. E 62 708
Yoo W J and Li C J 2006 J. Org. Chem. 71 6266
Li Z, Li H, Guo X, Cao L, yu Rango, Li H and Pan S 2008 Org. Lett. 10 803
Smith C D, Rosocha G, Mui L and Batey R A 2010 J. Org. Chem. 75 4716
Barluenga J, Riesgo L, Vicente R, Lopez Luis A and Tomas M 2007 J. Am. Chem. Soc. 129 7772
Kingsbury C A, Draney D, Sopchik A, Rissler W and Durham D 1976 J. Org. Chem. 41 3863
Kinnings S L, Liu N, Buchmeier N, Tonge P J, Xie L and Bourne P E 2009 Comput. Biol. 5 7
(a) Steuer C, Gege C, Fischl W, Karl H, Heinonen, Bartenschlager R and Klein C D 2011 Bioorg. Med. Chem. 19 4067; (b) Nitsche C, Steuer C and Klein C D 2011 Bioorg. Med. Chem. 19 7318; (c) Mueller N H, Pattabiraman N, Ansarah-Sobrinho C, Viswanathan P, Pierson T C and Padmanabhan R 2008 Antimicrob. Agents Chemother. 52 3385 41.
Padmanabhan R, Nagarajan K, Rao K S, Shridhara K, Shashiprabha and Harisha A S 2014 WO Patent 2014164667A 1
Acknowledgements
We thank Alkem laboratories of India for providing research facilities and OSDD CSIR for in vitro anti TB results.
Author information
Authors and Affiliations
Corresponding authors
Additional information
Supplementary Information
1H, 13C NMR, HSQC and 2D 1H-1H NOESY spectra for all new compounds are available. available at www.ias.ac.in/chemsci. Crystallographic data 2 (CCDC1027892), 23 (CCDC1027891), 25 (CCDC10 27893), 30 (CCDC1027894) and 32 (1027895) have been deposited at the Cambridge Crystallographic Database Centre and are available on request (http:www.ccdc.cam.ac.uk).
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
HARISHA, A.S., NAYAK, S.P., S, P.M. et al. A new synthesis of Entacapone and report on related studies. J Chem Sci 127, 1977–1991 (2015). https://doi.org/10.1007/s12039-015-0961-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12039-015-0961-4